ABEOABEONA THERAPEUTICS INC.vs its industry peers
A metric-by-metric comparison of ABEONA THERAPEUTICS INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABEOThis | $240M#6 | — | 1.9x#3 | 41.3x#5 | — | -211.7%#6 | -1536.9%#7 | -55.6%#4 | -121.6%#2 | — | -12.5%#1 | — |
| BIOA | $260M#1 | — | 0.7x#1 | 28.9x#4 | — | -13.4%#3 | -1031.5%#5 | -21.5%#2 | — | — | — | — |
| QTTB | $256M#2 | 2.7x#1 | 2.4x#4 | 4.8x#3 | — | 162.5%#1 | 31.5%#1 | 28.1%#1 | — | — | — | — |
| GLSI | $255M#3 | — | 81.8x#5 | — | — | -11.2%#2 | — | -621.1%#6 | — | — | — | — |
| BCYC | — | — | — | — | 105.8%#2 | -29.5%#4 | -340.4%#4 | -43.3%#3 | -372.9%#3 | — | — | — |
| CAMP | $251M#4 | — | — | 71.8x#6 | 436.5%#1 | -55.2%#5 | -1502.4%#6 | — | — | — | — | — |
| LFCR | $243M#5 | — | — | 1.9x#2 | 0.5%#4 | -422.5%#7 | -13.4%#2 | — | -28.7%#1 | 3#1 | — | — |
| VNDA | $227M#7 | — | 1.1x#2 | 1.0x#1 | 8.7%#3 | -1066.7%#8 | -70.0%#3 | -110.3%#5 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice